R&G PharmaStudies Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Northrop Grumman (Beijing) Pharmaceutical Technology Co., Ltd. (stock code: 301333SZ), as a well-known CRO company rooted in China and facing the world, adheres to the principle of "for human health", adheres to customer first, and adheres to the service philosophy of "scientific, professional, and innovative". It provides comprehensive and chain CRO services for clinical research and development for global pharmaceutical enterprises, improving the success rate of drug research and development, reducing risks, saving costs, and shortening cycles, Received widespread praise in the industry. Northrop Grumman was founded in 2008 and, after fourteen years of unremitting struggle, has created an excellent team of nearly 2000 people, achieving a brand new listed company with a mature corporate culture. It has nearly ten subsidiaries, covering registration affairs, clinical pharmacology, medical affairs and pharmacovigilance, data management and statistical analysis, clinical operations, center management, and biological sample analysis. Each professional field is led by top domestic and foreign experts, and the company's "Innovative Pharmaceutical Science and Strategy Committee" is formed to customize research and development strategies and top-level designs for domestic and foreign pharmaceutical enterprises, optimize clinical trial plans, guide the application of new drugs at home and abroad, and achieve outstanding results. So far, Northrop Grumman has served over 750 pharmaceutical companies, helping numerous medical device products, adopting innovative design and scientific methods, promoting efficient communication and exchange with CDE and FDA, and accelerating the launch of medical devices. In the trend of innovation and regulatory internationalization, and in the context of clinical value oriented pharmaceutical research and development, all colleagues at Northrop will continue to empower global pharmaceutical companies and benefit patients. |
| Headquarter | Beijing |
| Establish Date | 8/22/2008 |
| Listed Code | 301333.SZ |
| Listed Date | 8/2/2022 |
| Chairman | WU JIE. |
| CEO | WU JIE. |
| Website | www.rg-pharma.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
